Search by Drug Name or NDC
NDC 00093-9222-01 Diflunisal 500 mg/1 Details
Diflunisal 500 mg/1
Diflunisal is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is DIFLUNISAL.
MedlinePlus Drug Summary
Diflunisal is used to relieve pain, tenderness, swelling and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints). Diflunisal is also used to relieve mild to moderate pain from other causes. Diflunisal is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.
Related Packages: 00093-9222-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Diflunisal
Product Information
| NDC | 00093-9222 |
|---|---|
| Product ID | 0093-9222_1c3fbf36-5c3e-4b8c-8360-18135c230756 |
| Associated GPIs | 64100050000310 |
| GCN Sequence Number | 004443 |
| GCN Sequence Number Description | diflunisal TABLET 500 MG ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 16851 |
| HICL Sequence Number | 001847 |
| HICL Sequence Number Description | DIFLUNISAL |
| Brand/Generic | Generic |
| Proprietary Name | Diflunisal |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Diflunisal |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIFLUNISAL |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00093-9222-01 (00093922201)
| NDC Package Code | 0093-9222-01 |
|---|---|
| Billing NDC | 00093922201 |
| Package | 100 TABLET, FILM COATED in 1 BOTTLE (0093-9222-01) |
| Marketing Start Date | 2021-06-30 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.02606 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | DIFLUNISAL 500 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis